Back to News
Market Impact: 0.15

FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban

Source: businessinsider.com

Legal & LitigationRegulation & Legislation
FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban

The FTC said Martin Shkreli continues to trade pharmaceutical stocks despite a lifetime ban. The brief report provides no details on the trades or any specific market impact.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.25

More News

From AllMind Research

Browse all research